NITO vs RARE · rev $210.0K vs rev $350.0M
N2OFF Inc (NITO) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
N2OFF Inc (NITO) is a agricultural inputs company listed on NASDAQ.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported NITO revenue for 2024-12-31 was $210.0K. Net income was -$5.3M. Revenue was down 20.3% from 2023-12-31 to 2024-12-31. NITO currently screens at market cap $3.3M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
NITO currently screens at market cap $3.3M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the NITO and RARE stock pages for the full models.
Not investment advice.